Drug Profile


Alternative Names: AL 01576; AL 1576; HOE 843

Latest Information Update: 28 May 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alcon
  • Class Antihyperglycaemics; Fluorenes; Hydantoins; Small molecules
  • Mechanism of Action Aldehyde reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetic complications

Most Recent Events

  • 28 May 2002 Discontinued - Phase-III for Diabetic complications in USA (PO)
  • 22 May 2001 Profile reviewed but no significant changes made
  • 20 Dec 1995 A study has been added to the side effects section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top